Aziz Kabeer
SEC CIK 1914847 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ANTX | AN2 Therapeutics, Inc. | Dir, 10% | 59.1K | $2.50M | $3.98M | 17 | 2022-03-29 | 2026-07-10 |
Most active insiders at ANTX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Readnour Robin Shane | Dir | — | $316.7K |
| 2 | Eizen Joshua M | See Remarks | — | $52.9K |
| 3 | FitzPatrick Margaret M | Dir | $11.6K | — |
| 4 | Chanda Sanjay | Chief Development Off | — | $9,311 |
| 5 | Day Lucy | CFO | — | $8,862 |
| 6 | Prior Stephen David | Chief Strategy Off | — | $7,363 |
| 7 | Williams Sarah Joanne | Principal Accounting Off | — | $3,025 |
| 8 | Trenor Cameron C. III | Chief Medical Off | — | — |
| 9 | Marks Gilbert Lynn | Dir | — | — |
| 10 | Martin Patricia A. | Dir | — | — |
| 11 | Aziz Kabeer | Dir | — | — |
Transactions 17
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-07-10 19:41 | 2026-07-10 | ANTX | AN2 Therapeutics, Inc. | Aziz Kabeer | Dir | A - Grant | $0.00 | +2,852 | 59.1K | +5% | $0 | |
| 2026-04-10 20:58 | 2026-04-10 | ANTX | AN2 Therapeutics, Inc. | Aziz Kabeer | Dir | A - Grant | $0.00 | +3,775 | 56.3K | +7% | $0 | |
| 2026-01-14 | 2026-01-12 | ANTX | AN2 Therapeutics, Inc. | Aziz Kabeer | Dir | A - Grant | $0.00 | +11.6K | 52.5K | +28% | $0 | |
| 2025-10-14 | 2025-10-10 | ANTX | AN2 Therapeutics, Inc. | Aziz Kabeer | Dir | A - Grant | $0.00 | +10.4K | 40.9K | +34% | $0 | |
| 2025-07-11 | 2025-07-10 | ANTX | AN2 Therapeutics, Inc. | Aziz Kabeer | Dir | A - Grant | $0.00 | +11.9K | 30.6K | +64% | $0 | |
| 2025-04-11 | 2025-04-10 | ANTX | AN2 Therapeutics, Inc. | Aziz Kabeer | Dir | A - Grant | $0.00 | +9,705 | 18.7K | +108% | $0 | |
| 2024-12-23 | 2024-12-19 | ANTX | AN2 Therapeutics, Inc. | Aziz Kabeer | Dir | A - Grant | $0.00 | +8,972 | 8,972 | New | $0 | |
| MI | 2024-01-18 | 2024-01-16 | ANTX | AN2 Therapeutics, Inc. | Aziz Kabeer | Dir | S - Sale | $19.65 | -100.0K | 377.5K | -21% | -$1.96M |
| MTI | 2023-11-16 | 2023-11-14 | ANTX | AN2 Therapeutics, Inc. | Aziz Kabeer | Dir, 10% | S - Sale | $16.15 | -1,810 | 2.08M | -0.1% | -$29.2K |
| MI | 2023-10-03 | 2023-09-29+ | ANTX | AN2 Therapeutics, Inc. | Aziz Kabeer | Dir, 10% | S - Sale | $16.27 | -104.8K | 2.08M | -5% | -$1.70M |
| MI | 2023-09-29 | 2023-09-27+ | ANTX | AN2 Therapeutics, Inc. | Aziz Kabeer | Dir, 10% | S - Sale | $16.11 | -9,357 | 2.18M | -0.4% | -$150.7K |
| MI | 2023-09-15 | 2023-09-13 | ANTX | AN2 Therapeutics, Inc. | Aziz Kabeer | Dir, 10% | S - Sale | $16.00 | -400 | 2.18M | -0.0% | -$6,400 |
| MI | 2023-09-08 | 2023-09-06+ | ANTX | AN2 Therapeutics, Inc. | Aziz Kabeer | Dir, 10% | S - Sale | $16.03 | -7,140 | 412.5K | -2% | -$114.5K |
| MI | 2023-08-25 | 2023-08-23 | ANTX | AN2 Therapeutics, Inc. | Aziz Kabeer | Dir, 10% | S - Sale | $16.00 | -400 | 413.1K | -0.1% | -$6,400 |
| MI | 2022-06-24 | 2022-06-06 | ANTX | AN2 Therapeutics, Inc. | Aziz Kabeer | Dir, 10% | J - Other | $15.00 | 0 | 2.18M | New | $0 |
| DMI | 2022-03-31 | 2022-03-29 | ANTX | AN2 Therapeutics, Inc. | Aziz Kabeer | Dir, 10% | C - Cnv Deriv | — | +2.43M | 386.6K | New | — |
| DI | 2022-03-31 | 2022-03-29 | ANTX | AN2 Therapeutics, Inc. | Aziz Kabeer | Dir, 10% | P - Purchase | $15.00 | +166.7K | 2.21M | +8% | +$2.50M |
Purchase Sale Sale after option exercise All abbreviations